NSEAllotment of Securities1 Jul 2026 · 1 Jul 2026, 06:19 pm
Allotment of Securities
Vimta Labs Limited · VIMTALABS
✦ AI SummaryFundraise
Vimta Labs Limited has informed the Exchange regarding allotment of 17,549 securities pursuant to ESOP/ESPS at its meeting held on July 01, 2026. The paid-up share capital of the Company has increased from ₹ 8,93,38,710 consisting of 4,46,69,355 equity shares having a face value of ₹ 2/- each to ₹ 8,93,73,808 consisting of 4,46,86,904 equity shares having a face value of ₹ 2/- each.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vimta Labs Limited has informed the Exchange regarding allotment of 17549 securities pursuant to ESOP/ESPS at its meeting held on July 01, 2026
Attachments (1)
📄pdf
Download →
VIMTALABS_01072026181728_Reg_30.pdf
View document text
imla
Vimta Labs Limited
Registered Office
142, IDA Phase II, Cherlapally
Hyderabad-500 051, Telangana, India
T: .91 40 27264141
F: +91 40 27263657 Driven byQuality. Inspired byScience.
VLL\SE\026\2026-27
Date: 01.07.2026
B S E Limited, National Stock Exchange ofIndia Limited,
PJ Towers, Dalal Street, “Exchange Plaza”, Bandra, Kurla Complex,
Mumbai 400001. Bandra (E), Mumbai 400051.
Scrip Code: 524394 Trading Symbol: VIMTALABS
Dear Sir/Madam,
Sub: Mlotment ofEmployee Stock Options under “Vimta Labs Employee Stock Option
Plan 2021”
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that
the ESOT’ Allotment Committee ofthe Board ofDirectors ofthe Company at their meeting held
on July 2026, has allotted 17,549 equity shares offace value oftZ/- each, to the eligible
employees ofthe Company underVimta Labs Employee Stock Option Plan 2021.
Thepaid-up share capital ofthe Companyhas accordinglyincreased from Z 8,93,38,710 consisting
of 4,46,69,355 equity shares having a face value of t 2/- each to Z .8,93,73,808 consisting of
4,46,86,904 equity shares having a face value ofZ 2/- each.
Further, we would like to confirm that the above allotted shares shall rank pan passu with the
existing equity shares ofthe Company and the Company is in the process ofcompleting the other
formalities with respect to listing ofthe said allotted shares.
The details required as disclosure under Part E, Regulation 10(c) of SEBI ESOP Regulations are
enclosed as “Annexure-A”.
This is for yourinformation and records.
Thanking you,
ForVIMTA LABS LIMITED
Su~aniVasireddi
Company Secretary & Compliance Officer
Plot No. 5, Life Sciences Facility, Neovantage Science&Technology Park Private Limited, Siamirpet, GenomeValley, Turkapally
Medchal-Malkajgiri, Hyderabad-500101, Telangana, India.T: +91 4067404040 E : mdoffice@vimta.com URL:wwwvimta.com
GIN: L24110TG1990PLG011977
Vimta Labs Limited *
Registered Office
162, IDAPhaseII, Cherlapally
Hyderabad-500 051,Telangana, India
T: ~91 4027264141 Is
Driven by Quality. Inspired byScience.
F : +91 4027263657
Annexure-A
Disclosure under Part E pursuant to Regulation 10(c) of SEBI (Share Based Employee
Benefits and Sweat Equity) Regulations, 2021
SI. Particulars Details
Company name and address of Vimta Labs Limited
Registered Office: Plot No. 142, IDA, Phase-Il, Cherlapally, Hyderabad,
Telangana 500051
2 Name of the recognised Stock BSE Limited
Exchanges on which the company’s National Stock Exchange ofIndia limited
shares are listed
3 Filing date ofthe statement referred in BSE Limited
regulation 10(b) of the Securities and
Fthng date: 28.07.2021; The Company had received ‘in-
Exchange Board ofIndi.a (Share Based
Employee Benefits and Sweat Equity) principle’ listing approval from BSE vide letter dated
Regulations, 2021 with the recognized 15.09.2021 for 6,63,234 equity shares.
Stock Exchange Post Bonus Issue annlication:
Date ofApplication- 01”July 2025.
The Company had received ‘in-principle’ listing approval
from BSE vide letter dated 29.08.2025 for additional
5,18,260 equity shares in addition to the above in-principle
approval letter.
National Stock Exchange ofIndia Limited
Filing date: 28.07.2021; The Company had received ‘in-
principle’ listing approval from NSE vide letter dated
06.08.2021 for 6,63,234 equity shares.
Post Bonus Issue anplication:
Date ofApplication- 0I”July 2025.
The Company had received ‘in-principle’ listing approval
from NSE vide letter dated 01.09.2025 for additional
5,18,260 equity shares in addition to the above in-principle
approval letter.
4 FilingNumber, ifany BSE: DCS/FL/MJ/ESOP-IP/1472/2021-22
BSE: DCS/ESOP/IP/NB/3709/2025-26
NSE: NSE/LIST/27779
NSE: NSE/LIST/49464
5 Tide ofthe Scheme pursuant to which Vimta Labs Employee Stock Option Plan 2021
shares are issued, ifany:
6 Kind ofsecurity to be listed Equity Shares
7 Parvalue ofthe shares
PlotNo. 5, LifeSciences Facility, NeovantageScience &Technology Park Private Limited, Sharnirpet Ge
Medchal-Malkajgiri, Hyderabad-500 101,Telangana, India. T: +91 40 67404040 F: mdoffice@vimta.com
CIN : L24110TG1990PLC011977
Vimta Labs Limited
Registered Office
142, IDA Phase II, Cherlapally
Hyderabad-500 051,Telangana, India
T: +91 40 27264141
F: +914027263657 Driven byQuality. Inspired byScience.
Particulars Details
Date ofissue ofshares O1~July 2026
Number ofshares issued 17,549
Share Certificate No., ifapplicable NotApplicable.
Distinctive number of the share, if 48369356-48386904(Both Inclusive)
applicable:
ISIN Number ofthe shares ifissued in 1NE579C01029
Demat
Exercise price per share Z 2/-
Premiurñ per share NotApplicable.
Total Issued shares after this issue 4,46,86,904
Total issued share capital after this ~ 8,93,73,808
issue
Details ofany lock-in on the shares NotApplicable
Date ofexpiry oflock-in NotApplicable
Whether shares are identical in all All equity shares of the Company allotted pursuant to
respects to existing shares? If not, exercise of stock options shall rank pari-passu with the
when will they become identical? existin. e.ui shares ofthe Comian
Details oflisting fees, ifpayable NotApplicable
Plot No. 5, Life Sciences Facility, Neovantage Science &Technology Park Private Limited, Shamirpet, GenomeValley, Turkapally
Medchal-Malkajgiri, Hyderabad-500101, Telangana. India.T: +91 40 67404040 E: mdoffice@vimta.com URL : www.vimta.com
GIN L24110TG1990PLC011977